首页>
外国专利>
PROLONGED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR PEPTIDE DELIVERY
PROLONGED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR PEPTIDE DELIVERY
展开▼
机译:肽释放的延长释放药物成分
展开▼
页面导航
摘要
著录项
相似文献
摘要
FIELD: medicine, pharmaceutics.;SUBSTANCE: invention refers to medicine. What is presented is a liquid polymeric pharmaceutical composition for controlled release of a therapeutic polypeptide containing pharmaceutically acceptable, water-insoluble, a biodegradable polymer, a pharmaceutically acceptable organic solvent and a therapeutic polypeptide conjugated with one or more lipophilic groups and/or with one or more amphiphilic groups. What is presented is a method for preparing said composition involving the stage of dissolving the biodegradable polymer in the pharmaceutically acceptable organic solvent and the stage of mixing the prepared polymer solution with an effective amount of the therapeutic polypeptide.;EFFECT: invention provides producing the pharmaceutical composition showing higher stability in vitro and reduced initial "explosive" release of the therapeutic polypeptide in comparison with the composition wherein the therapeutic polypeptide is not conjugated with the lipophilic and/or amphiphilic groups.;17 cl, 4 dwg, 3 tbl, 14 ex
展开▼
机译:领域:药物,药品;物质:发明是指药物。提供了用于控制释放治疗性多肽的液体聚合物药物组合物,所述治疗性多肽包含与一个或多个亲脂基团和/或与一个或多个亲脂性基团缀合的药学上可接受的,水不溶性,生物可降解的聚合物,药学上可接受的有机溶剂和治疗多肽。更多两亲群体。提供了一种制备所述组合物的方法,该方法包括将可生物降解的聚合物溶解在药学上可接受的有机溶剂中的阶段以及将所制备的聚合物溶液与有效量的治疗性多肽混合的阶段。效果:本发明提供了制备药物的方法与其中治疗性多肽不与亲脂性和/或两亲性基团不缀合的组合物相比,该组合物在体外显示出更高的稳定性并减少了治疗性多肽的初始“爆炸性”释放。; 17 cl,4 dwg,3 tbl,14 ex
展开▼